Neuromyelitis optica relapses: race and rate, immunosuppression and impairment
<p><i>Objective</i> Neuromyelitis optica (NMO) is a rare antibody-mediated CNS disease characterised by disabling relapses leading to high morbidity and mortality. Understanding relapse activity and severity is important for treatment decisions and clinical trial design. We assess...
Main Authors: | Tackley, G, O'Brien, F, Rocha, J, Woodhall, M, Waters, P, Chandratre, S, Halfpenny, C, Hemingway, C, Wassmer, E, Wasiewski, W, Leite, M, Palace, J |
---|---|
Formato: | Journal article |
Publicado em: |
Elsevier
2016
|
Registos relacionados
-
Risk factors for immunosuppression-associated infections in aquaporin-4 antibody mediated neuromyelitis optica spectrum disorders
Por: Cheng, F, et al.
Publicado em: (2014) -
Good response to Ofatumumab in a child with severe relapsing Neuromyelitis Optica
Por: Sedani, S, et al.
Publicado em: (2012) -
Seasonal pattern of variation in neuromyelitis optica relapses
Por: Elsone, L, et al.
Publicado em: (2012) -
Magnetic resonance imaging in neuromyelitis optica.
Por: Tackley, G, et al.
Publicado em: (2014) -
Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features.
Por: Absoud, M, et al.
Publicado em: (2014)